awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36892821-5E517D7B-ADC8-494F-AAF3-400D347E226A
Q36892821-5E517D7B-ADC8-494F-AAF3-400D347E226A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36892821-5E517D7B-ADC8-494F-AAF3-400D347E226A
A randomized, phase II, three-arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first-line therapy for metastatic breast cancer.
P2860
Q36892821-5E517D7B-ADC8-494F-AAF3-400D347E226A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36892821-5E517D7B-ADC8-494F-AAF3-400D347E226A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3b675a22222dcaa9e3c6e4887071717b4ae13aac
P2860
Randomized phase III trial of ixabepilone plus capecitabine versus capecitabine in patients with metastatic breast cancer previously treated with an anthracycline and a taxane